Delphia (USA)’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,940
Closed -$88K 392
2022
Q2
$88K Buy
+16,940
New +$88K 0.06% 349